Menadiol sodium diphosphate
Kappadione, Synkayvite (menadiol sodium diphosphate) is a small molecule pharmaceutical. Menadiol sodium diphosphate was first approved as Kappadione on 1982-01-01.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
155 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Atrial fibrillation | D001281 | EFO_0000275 | I48.0 | 1 | 6 | 10 | 8 | 20 | 44 |
| Hemorrhage | D006470 | MP_0001914 | R58 | — | — | 6 | 3 | 7 | 16 |
| Venous thromboembolism | D054556 | EFO_0004286 | I74 | — | 3 | 7 | 1 | 5 | 14 |
| Thrombosis | D013927 | — | — | 1 | 4 | 5 | 1 | 1 | 12 |
| Pulmonary embolism | D011655 | EFO_0003827 | I26 | — | 1 | 4 | 3 | 3 | 10 |
| Venous thrombosis | D020246 | — | I82.40 | 1 | 3 | 4 | 1 | 2 | 10 |
| Chronic renal insufficiency | D051436 | — | N18 | — | — | 2 | 1 | 1 | 4 |
| Atrial flutter | D001282 | EFO_0003911 | — | — | 1 | 2 | 1 | — | 3 |
| Heart failure | D006333 | EFO_0003144 | I50 | — | — | 1 | 1 | — | 2 |
| Hematoma | D006406 | EFO_0010680 | — | — | — | 1 | 1 | — | 2 |
Show 16 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Stroke | D020521 | EFO_0000712 | I63.9 | 2 | 1 | 6 | — | 6 | 14 |
| Thromboembolism | D013923 | — | — | — | — | 7 | — | 2 | 9 |
| Embolism | D004617 | — | — | 1 | — | 3 | — | 2 | 6 |
| Intracranial hemorrhages | D020300 | EFO_0000551 | I62 | — | — | 2 | — | 2 | 4 |
| Chronic kidney failure | D007676 | EFO_0003884 | N18.6 | — | 2 | 2 | — | 1 | 4 |
| Kidney diseases | D007674 | EFO_0003086 | N08 | — | — | 2 | — | 1 | 3 |
| Drug-related side effects and adverse reactions | D064420 | — | T88.7 | — | — | 1 | — | 2 | 3 |
| Heart valve diseases | D006349 | EFO_0009551 | I08 | — | 2 | 1 | — | 1 | 3 |
| Neoplasms | D009369 | — | C80 | 2 | — | 1 | — | — | 3 |
| Hemostatic disorders | D020141 | — | — | — | 1 | 2 | — | — | 2 |
Show 23 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Healthy volunteers/patients | — | — | — | 6 | 1 | — | — | 5 | 12 |
| Cerebral hemorrhage | D002543 | — | — | — | 1 | — | — | 1 | 2 |
| Sickle cell anemia | D000755 | EFO_0000697 | D57 | 1 | 1 | — | — | — | 2 |
| Fibrosis | D005355 | — | — | — | 1 | — | — | 1 | 2 |
| Cystic fibrosis | D003550 | EFO_0000390 | E84 | — | 1 | — | — | 1 | 2 |
| Inflammation | D007249 | MP_0001845 | — | — | 1 | — | — | — | 1 |
| Chronic pancreatitis | D050500 | EFO_0000342 | K86.1 | — | 1 | — | — | — | 1 |
| Exocrine pancreatic insufficiency | D010188 | — | K86.81 | — | 1 | — | — | — | 1 |
| Hypercholesterolemia | D006937 | — | — | — | 1 | — | — | — | 1 |
| Pulmonary hypertension | D006976 | EFO_0001361 | I27.20 | — | 1 | — | — | — | 1 |
Show 4 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Psoriasis | D011565 | EFO_0000676 | L40 | 3 | — | — | — | — | 3 |
| Rheumatoid arthritis | D001172 | EFO_0000685 | M06.9 | 2 | — | — | — | — | 2 |
| Arthritis | D001168 | EFO_0005856 | M05-M14 | 2 | — | — | — | — | 2 |
| Hypersensitivity | D006967 | EFO_0003785 | T78.40 | 1 | — | — | — | — | 1 |
| Ulcerative colitis | D003093 | EFO_0000729 | K51 | 1 | — | — | — | — | 1 |
| Crohn disease | D003424 | EFO_0000384 | K50 | 1 | — | — | — | — | 1 |
| Colitis | D003092 | EFO_0003872 | K52.9 | 1 | — | — | — | — | 1 |
| Ulcer | D014456 | MPATH_579 | — | 1 | — | — | — | — | 1 |
| Alzheimer disease | D000544 | EFO_0000249 | F03 | 1 | — | — | — | — | 1 |
| Recurrence | D012008 | — | — | 1 | — | — | — | — | 1 |
Show 8 more
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Ischemic stroke | D000083242 | — | — | — | — | — | — | 3 | 3 |
| Vitamin k deficiency | D014813 | — | E56.1 | — | — | — | — | 3 | 3 |
| Micronutrients | D018977 | — | — | — | — | — | — | 2 | 2 |
| Bone fractures | D050723 | EFO_0003931 | T14.8 | — | — | — | — | 2 | 2 |
| Aging | D000375 | GO_0007568 | R41.81 | — | — | — | — | 2 | 2 |
| Coronary artery disease | D003324 | — | I25.1 | — | — | — | — | 1 | 1 |
| Gastrointestinal hemorrhage | D006471 | — | K92.2 | — | — | — | — | 1 | 1 |
| Renal insufficiency | D051437 | — | N19 | — | — | — | — | 1 | 1 |
| Osteoporosis | D010024 | EFO_0003882 | M81.0 | — | — | — | — | 1 | 1 |
| Medication adherence | D055118 | EFO_0006344 | — | — | — | — | — | 1 | 1 |
Show 27 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | Menadiol sodium diphosphate |
| INN | _ |
| Description | Kappadione, Synkayvite (menadiol sodium diphosphate) is a small molecule pharmaceutical. Menadiol sodium diphosphate was first approved as Kappadione on 1982-01-01. |
| Classification | Small molecule |
| Drug class | — |
| Image (chem structure or protein) |  |
| Structure (InChI/SMILES or Protein Sequence) | Cc1cc(OP(=O)([O-])[O-])c2ccccc2c1OP(=O)([O-])[O-].O.O.O.O.O.O.[Na+].[Na+].[Na+].[Na+] |
Identifiers
| PDB | — |
| CAS-ID | 205-012-1 |
| RxCUI | — |
| ChEMBL ID | CHEMBL3989728 |
| ChEBI ID | — |
| PubChem CID | — |
| DrugBank | — |
| UNII ID | 2OVL75B30W (ChemIDplus, GSRS) |
Target
No data
Variants
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 467 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use